Your browser doesn't support javascript.
loading
A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases.
Ni, Yangyue; Xiong, Ruiyan; Zhu, Yuxiao; Luan, Ning; Yu, Chuanxin; Yang, Kun; Wang, Huiquan; Xu, Xuejun; Yang, Yuxuan; Sun, Siyu; Shi, Liyun; Padde, Jon Rob; Chen, Lin; Chen, Lu; Hou, Min; Xu, Zhipeng; Lai, Ren; Ji, Minjun.
Affiliation
  • Ni Y; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Xiong R; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Zhu Y; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Luan N; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, China.
  • Yu C; Jiangsu Institute of Parasitic Diseases, Wuxi, China.
  • Yang K; Jiangsu Institute of Parasitic Diseases, Wuxi, China.
  • Wang H; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Xu X; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Yang Y; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Sun S; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Shi L; Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, China.
  • Padde JR; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Chen L; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Chen L; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Hou M; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Xu Z; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Lai R; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, China. Electronic address: rlai@mail.kiz.ac.cn.
  • Ji M; Department of Pathogen Biology, National Vaccine Innovation Platform, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China. Electronic address: jiminjun@njmu.edu.cn.
EBioMedicine ; 95: 104751, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37579625
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Psoriasis / Schistosoma japonicum / Autoimmune Diseases / Colitis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: EBioMedicine Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Psoriasis / Schistosoma japonicum / Autoimmune Diseases / Colitis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: EBioMedicine Year: 2023 Document type: Article